| Suggest |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Personal Finance > Debt Management - Watch Out for Bank Fees! |
|
Suggest - Debt Management - Watch Out for Bank Fees!
During the last twenty years, banks have offered a number of improvements in the area of being customer-friendly. T According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product he old 9 AM – 2 PM “banker’s hours” are gone, replaced by a schedule that makes it easy for most people to visit whe ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in n the bank is open. Automatic teller machines are ubiquitous, making it easier to obtain cash even when the banks a lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. e closed. And the debit card has made it easier than ever to pay for an item – you don’t even have to write a check here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe anymore. Such conveniences come with a price, however, and banks are charging additional fees for all sorts of ser d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro vices. Some of them can be quite steep, and consumers should watch how they manage the money they have in the bank. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Banks have been talking for years about how convenient it is to use an automatic teller machine. You can use one 2 easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi 4 hours a day and the handy machines often make it unnecessary to interact with a teller. What many banks fail to a nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically dvertise, however, is that they now charge a fee for any transaction that involves a teller. Most people probably w and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ uldn’t care to pay a $3 fee to walk into a bank to deposit a check, but since many banks charge such a fee, consumer ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi s should check their bank statements carefully. Automatic teller machines are certainly convenient, but their use i ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a s now mandatory at some banks for no-fee transactions. Something else consumers should watch out for is overdraft f dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod es. Many banks now offer overdraft protection; you can use your debit card or checkbook to make purchases that exce cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ed the balance in your account. In years past, the bank would have returned the check or denied the debit purchase; tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen now they let the purchase go through. This comes at a cost; the average fee for an overdraft charge is $25. Shoul t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel you exceed your balance by a mere $10, the $25 charge amounts to a 250% interest rate on the short-term loan of ten ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust dollars. The overdraft business is a good one; banks nationwide earned about ten billion dollars last year on over y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products draft charges alone. There are many other situations that banks use to tack on fees, and some of them aren’t all th . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de t obvious. In order to make sure that your bank isn’t charging you more than you’d like for your business with them elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip , make sure that you read your statement carefully. If not, the “convenience” of banking could come at a high price tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:More About Bad Credit Debt Consolidation Loans
|